Oral Cancer Treatment Market Size, Report, Share, and Forecast by 2023-2028
According to the latest report by IMARC Group, titled "Oral Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a comprehensive analysis of the industry, which comprises insights into the oral cancer treatment market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global oral cancer treatment market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.50% during 2023-2028.
Oral Cancer Treatment Market Outlook:
Oral cancer treatment refers to the diagnosis and treatment of cancer that occurs in the tissues of lips, gums, inner lining of the cheeks, tongue, and the upper and lower floor of the mouth cavity. It comprises a wide variety of methods, such as surgery, chemotherapy, and radiation, wherein mostly X-rays are used to kill malignant cells forming tumors or lumps. It relies on various imaging tests, such as X-ray images, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. Oral cancer treatment is carried out by an oncologist who initially examines the affected area to spot any abnormalities, carries out testing procedures or biopsy to detect cancer cells, and suggests the appropriate treatment to prevent the spread of cancer. As it is effective in treating cancer cells in salivary glands, tonsils, pharynx, and gums, the demand for oral cancer treatment is rising across the globe.
Get Free Sample Copy of Report at –
https://www.imarcgroup.com/oral-cancer-treatment-market/requestsample
Global Oral Cancer Treatment Market Trends:
At present, the increasing occurrence of oral cancer among the masses due to excessive smoking of cigars, cigarettes, and pipes and chewing of tobacco represents one of the primary factors influencing the market positively. Besides this, the rising adoption of smoking habits among youngsters influenced by peer pressure is propelling the growth of the market. In addition, governing agencies of various countries are investing in the improvement of healthcare infrastructure and increasing the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients. Apart from this, the growing awareness about the early detection and treatment of oral cancer is offering a favorable market outlook. Additionally, the rising innovation and research activities by key players to develop effective and accurate treatment methods and immunotherapy drugs for oral cancer are supporting the growth of the market.
Key Market Segmentation:
Competitive Landscape:
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
Type Insights:
- Oral Squamous Cell Carcinoma
- Oral Verrucous Carcinoma
- Mucoepidermoid Carcinoma
- Oral Cavity Lymphomas
Treatment Type Insights:
- Chemotherapy
- Radiation Therapy
- Targeted Therapy
- Surgery
- Others
Age Group Insights:
- 30-49
- 50-69
- Above 70
End-User Insights:
- Hospital
- Home Care
- Specialty Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800
Comments
Post a Comment